Park SJ - Search Results

1

Synthesis and anticancer activity of 4-aza-daurinol derivatives.

Hayat F, Park SH, Choi NS, Lee J, Park SJ, Shin D. Hayat F, et al. Among authors: park sj, park sh. Arch Pharm Res. 2015 Nov;38(11):1975-82. doi: 10.1007/s12272-015-0619-2. Epub 2015 Jun 6. Arch Pharm Res. 2015. PMID: 26048036

2

Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo.

Park SY, Gurung R, Hwang JH, Kang JH, Jung HJ, Zeb A, Hwang JI, Park SJ, Maeng HJ, Shin D, Oh SH. Park SY, et al. Among authors: park sj. Redox Biol. 2023 Aug;64:102783. doi: 10.1016/j.redox.2023.102783. Epub 2023 Jun 15. Redox Biol. 2023. PMID: 37348157 Free PMC article.

3

Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.

Choi J, Park SJ, Jee JG. Choi J, et al. Among authors: park sj. Eur J Med Chem. 2015 Dec 1;106:157-66. doi: 10.1016/j.ejmech.2015.10.033. Epub 2015 Oct 19. Eur J Med Chem. 2015. PMID: 26544630

4

Brain energy metabolism and multiple sclerosis: progress and prospects.

Park SJ, Choi JW. Park SJ, et al. Arch Pharm Res. 2020 Oct;43(10):1017-1030. doi: 10.1007/s12272-020-01278-3. Epub 2020 Oct 29. Arch Pharm Res. 2020. PMID: 33119885 Review.

5

Ensemble-Based Virtual Screening Led to the Discovery of New Classes of Potent Tyrosinase Inhibitors.

Choi J, Choi KE, Park SJ, Kim SY, Jee JG. Choi J, et al. Among authors: park sj. J Chem Inf Model. 2016 Feb 22;56(2):354-67. doi: 10.1021/acs.jcim.5b00484. Epub 2016 Jan 20. J Chem Inf Model. 2016. PMID: 26750991

6

Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors.

Kim B, Park H, Lee SK, Park SJ, Koo TS, Kang NS, Hong KB, Choi S. Kim B, et al. Among authors: park h, park sj. Eur J Med Chem. 2016 Nov 10;123:777-787. doi: 10.1016/j.ejmech.2016.08.003. Epub 2016 Aug 6. Eur J Med Chem. 2016. PMID: 27541261

7

Structure-based design of peptides that trigger Streptococcus pneumoniae cell death.

Kang SM, Jin C, Kim DH, Park SJ, Han SW, Lee BJ. Kang SM, et al. Among authors: park sj. FEBS J. 2021 Mar;288(5):1546-1564. doi: 10.1111/febs.15514. Epub 2020 Aug 31. FEBS J. 2021. PMID: 32770723 Free PMC article.

8

Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain.

Kim HH, Hyun JS, Choi J, Choi KE, Jee JG, Park SJ. Kim HH, et al. Among authors: park sj. Sci Rep. 2018 Jan 10;8(1):368. doi: 10.1038/s41598-017-18332-8. Sci Rep. 2018. PMID: 29321504 Free PMC article.

9

Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity.

Kim DG, Cho S, Lee KY, Cheon SH, Yoon HJ, Lee JY, Kim D, Shin KS, Koh CH, Koo JS, Choi Y, Lee HH, Oh YK, Jeong YS, Chung SJ, Baek M, Jung KY, Lim HJ, Kim HS, Park SJ, Lee JY, Lee SJ, Lee BJ. Kim DG, et al. Among authors: park sj. Cell Mol Life Sci. 2021 Jan;78(1):207-225. doi: 10.1007/s00018-020-03490-2. Epub 2020 Mar 5. Cell Mol Life Sci. 2021. PMID: 32140747 Free PMC article.

10

Structural overview of toxin-antitoxin systems in infectious bacteria: a target for developing antimicrobial agents.

Park SJ, Son WS, Lee BJ. Park SJ, et al. Biochim Biophys Acta. 2013 Jun;1834(6):1155-67. doi: 10.1016/j.bbapap.2013.02.027. Epub 2013 Feb 28. Biochim Biophys Acta. 2013. PMID: 23459128 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,208 results

Search Page